4.7 Article

Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

The social origins of obesity within and across generations

Erik Hemmingsson et al.

Summary: This article proposes a model for the development of obesity, which suggests that social adversity, both within and across generations, plays a significant role, in conjunction with genetic predisposition. By focusing on three main areas, namely social adversity within the family, increasing levels of insecurity and chronic stress, and weight gain and obesity, the article highlights the impact of social factors on the transmission and development of obesity. Prevention efforts should therefore aim to address various forms of social adversity, such as poverty and inadequate education.

OBESITY REVIEWS (2023)

Article Cell Biology

Article Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARg-Cd36 pathway

Li Li et al.

Summary: The therapeutic potential of Orm2, a protein predominantly secreted by hepatocytes, for treating NAFLD and NASH was investigated in this study. The results showed that high Orm2 expression prevented obesity induced by a high-fat diet in mice. The pharmacological administration of recombinant ORM2 protein ameliorated hepatic steatosis, inflammation, hepatocyte injury, and fibrosis in mouse livers afflicted by NAFLD and NASH. Overall, Orm2 plays a critical role in preventing NASH and associated NAFLD in the context of obesity.

CELL REPORTS (2023)

Review Cell Biology

Why does obesity cause diabetes?

Samuel Klein et al.

Summary: The accumulation of excessive body fat can lead to type 2 diabetes, and the risk of type 2 diabetes increases with an increase in body mass index. The global increase in obesity has therefore resulted in a corresponding increase in the prevalence of type 2 diabetes. The mechanisms linking obesity and type 2 diabetes involve complex changes in b cell function, adipose tissue biology, and multi-organ insulin resistance, which can be improved or even normalized through weight loss.

CELL METABOLISM (2022)

Review Immunology

Inflammation in obesity, diabetes, and related disorders

Theresa Rohm et al.

Summary: Obesity can cause chronic systemic inflammation, leading to insulin resistance, beta-cell dysfunction, and ultimately type 2 diabetes. This inflammatory state also contributes to long-term complications of diabetes and may be associated with other conditions like Alzheimer's disease and polycystic ovarian syndrome.

IMMUNITY (2022)

Article Food Science & Technology

Clostridium butyricum Inhibits Fat Deposition via Increasing the Frequency of Adipose Tissue-Resident Regulatory T Cells

Haifang Li et al.

Summary: This study demonstrates that butyrate inhibits fat deposition by increasing the number of adipose tissue-resident Treg cells, and suggests its potential therapeutic interventions in obesity and related disorders.

MOLECULAR NUTRITION & FOOD RESEARCH (2022)

Article Cell Biology

Bifidobacterium infantis treatment promotes weight gain in Bangladeshi infants with severe acute malnutrition

Michael J. Barratt et al.

Summary: Disrupted development of the gut microbiota is a contributing cause of childhood malnutrition. An experiment found that giving B. infantis combined with LNT can increase the abundance of B. infantis subspecies in infants with severe acute malnutrition and promote weight gain, but the effect is still much lower than in healthy controls. A B. infantis strain, Bg_2D9, with superior fitness may have potential in treating malnourished infants.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Biology

Key features of the genetic architecture and evolution of host-microbe interactions revealed by high-resolution genetic mapping of the mucosa-associated gut microbiome in hybrid mice

Shauni Doms et al.

Summary: This study investigates the impact of host genetics on gut microbial traits using a powerful genetic mapping approach. The results reveal high heritability of mucosa-associated bacterial taxa and identify 428 genetic loci influencing these bacteria through genome-wide association mapping. Additionally, candidate genes associated with human diseases and immune function are identified.

ELIFE (2022)

Review Immunology

Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes

Vanessa Fernandes Rodrigues et al.

Summary: A. muciniphila is a beneficial bacterium that colonizes the intestinal mucosa and shows potential as an immunomodulatory probiotic for autoimmune and chronic inflammatory diseases. It has been found to slow down the development and progression of diseases such as diabetes, obesity, and IBD in mice.

FRONTIERS IN IMMUNOLOGY (2022)

Article Microbiology

TLR4 regulates RORγt+ regulatory T-cell responses and susceptibility to colon inflammation through interaction with Akkermansia muciniphila

Yaojiang Liu et al.

Summary: TLR4 plays a protective role in preventing intestinal inflammation by modulating immune responses associated with A. muciniphila. This finding provides a new perspective on host-commensal symbiosis and may contribute to the development of potential therapeutic strategies.

MICROBIOME (2022)

Article Multidisciplinary Sciences

Codiversification of gut microbiota with humans

Taichi A. Suzuki et al.

Summary: The gut microbiomes of human populations worldwide have common core microbial species. However, within a species, certain strains show population specificity. This study suggests that humans and their gut microbes have experienced parallel evolutionary history, and specific microbial strains may play a crucial role in microbiome-mediated disease phenotypes.

SCIENCE (2022)

Review Nutrition & Dietetics

Gut microbiota and obesity: New insights

Yoredy Sarmiento-Andrade et al.

Summary: Obesity is a globally increasing pathology with many associated disorders. In recent years, there has been growing knowledge about the influence of the microbiota on obesity and its related pathologies. This review summarizes the biology and physiology of microbiota in obese patients, as well as the therapeutic applications of prebiotics, probiotics, and fecal microbiota transplantation.

FRONTIERS IN NUTRITION (2022)

Article Endocrinology & Metabolism

Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis

Bing Zhou et al.

Summary: Alterations in hepatic lipid metabolism may contribute to the onset of non-alcoholic fatty liver disease. Zhou et al. identify orosomucoid 2 (ORM2) as a key regulator of lipid homeostasis in the liver. ORM2 activates the AMP-activated protein kinase signaling to inhibit lipogenesis. Additionally, injections of ORM2 protein improved liver steatosis and atherosclerosis.

NATURE METABOLISM (2022)

Review Critical Care Medicine

The central and biodynamic role of gut microbiota in critically ill patients

Hannah Wozniak et al.

Summary: Gut microbiota plays a crucial role in health and disease. Dysbiosis, characterized by altered composition of the microbiota, can lead to organ failure and impact the progression of critical diseases. Dysbiosis also affects gut integrity and metabolite production.

CRITICAL CARE (2022)

Article Immunology

Risk factors of Clostridium difficile- associated diarrhea in hospitalized adults: Vary by hospitalized duration

Yuan-Pin Hung et al.

Summary: The risk factors of Clostridium difficile-associated diarrhea (CDAD) vary among hospitalized patients with different lengths of hospital stay. Malignancy, prior cephalosporin, and proton pump inhibitor therapy are independent risk factors for CDAD. Intervention strategies for preventing CDAD may need to be tailored based on the duration of hospital stay.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Review Microbiology

Gut microbiota in human metabolic health and disease

Yong Fan et al.

Summary: The intestinal microbiota plays a significant role in human metabolic health, potentially contributing to the development of common metabolic disorders when dysregulated. Current research is shifting towards cause-and-effect studies and utilizing high-throughput human multi-omics data to identify potential molecular mechanisms behind these associations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Genetics & Heredity

Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome

Malte Christoph Ruehlemann et al.

Summary: The intestinal microbiome is considered an important modulating factor in inflammatory, neurologic, and neoplastic diseases. Host genetics may play a role in driving the composition of the microbiome. Genetic loci associated with single bacteria and overall microbiome composition have been identified, with potential causative and protective effects of gut microbes on diseases like inflammatory bowel disease.

NATURE GENETICS (2021)

Review Health Care Sciences & Services

Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis

Irina N. Grigor'eva

Summary: Obesity is a major risk factor for developing gallstone disease, possibly related to alterations in the gut microbiota. Studies on the gut microbiota in patients with GSD have shown significant changes in specific bacterial phyla. The impact of GSD on microbial diversity and the Firmicutes/Bacteroidetes ratio remains unclear.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Microbiology

Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models

Francesco Strati et al.

Summary: Different antibiotic treatments influence the gut microbiota's ability to control intestinal inflammation by altering the microbial community structure and production of metabolites, as observed in experimental colitis models.

MICROBIOME (2021)

Article Pharmacology & Pharmacy

Lactobacillus fermentum CECT5716 ameliorates high fat diet-induced obesity in mice through modulation of gut microbiota dysbiosis

Jose Alberto Molina-Tijeras et al.

Summary: Studies have shown that Lactobacillus fermentum CECT5716 demonstrates anti-obesity effects in a model of high fat diet-induced obesity in mice, along with improvements in anti-inflammatory properties, endothelial dysfunction, and gut dysbiosis. This probiotic modulates the microbiome by increasing beneficial bacteria abundance, reducing harmful bacterial presence, suggesting a potential use in the treatment of obesity.

PHARMACOLOGICAL RESEARCH (2021)

Article Cell Biology

Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis

Qing Wu et al.

Summary: Accumulating evidence suggests that gut microbiota regulates obesity through metabolite-host interactions. This study found that intestinal HIF-2 alpha controls lactate levels in the gut, impacting the microbiome abundance and adipose tissue thermogenesis. Manipulating these interactions may offer novel strategies for alleviating obesity.

CELL METABOLISM (2021)

Article Biochemistry & Molecular Biology

The anti-obesity effects exerted by different fractions of Artemisia sphaerocephala Krasch polysaccharide in diet-induced obese mice

Junjun Li et al.

Summary: Artemisia sphaerocephala Krasch polysaccharide (ASKP) and its two fractions, 60P and 60S, exhibited similar anti-obesity effects in high-fat-diet-fed mice by reducing body weight gain, improving dyslipidemia, systematic inflammation, and gut dysbiosis. They also demonstrated potential in acting as prebiotics to prevent obesity induced by high-fat-diet.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Multidisciplinary Sciences

Caloric restriction disrupts the microbiota and colonization resistance

Reiner Jumpertz von Schwartzenberg et al.

Summary: This study highlights the significant impact of diet on shaping the gut microbiome and influencing host metabolism. Restriction of calories led to changes in bacterial abundance and microbial composition, affecting nutrient absorption and resulting in metabolic phenotypes in mice. Further research is needed to understand the complex interactions between diet, microbiome, and host health.

NATURE (2021)

Review Nutrition & Dietetics

Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review

Hang-Yu Li et al.

Summary: PPSP are beneficial in managing metabolic diseases, mainly through mechanisms such as modulation of gut microbiota, regulation of microbial metabolites, and improvement of intestinal barrier function.

NUTRIENTS (2021)

Article Immunology

Lactulose Improves Neurological Outcomes by Repressing Harmful Bacteria and Regulating Inflammatory Reactions in Mice After Stroke

Quan Yuan et al.

Summary: The study demonstrates that lactulose supplementation improves neurological function after stroke by reducing inflammation, repairing intestinal barrier damage, and ameliorating gut dysbiosis and metabolic disorders.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Structural variation in the gut microbiome associates with host health

David Zeevi et al.

NATURE (2019)

Article Multidisciplinary Sciences

T cell-mediated regulation of the microbiota protects against obesity

Charisse Petersen et al.

SCIENCE (2019)

Article Cell Biology

The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs

Anthony T. Virtue et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Multidisciplinary Sciences

Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction

Eirini Giannoudaki et al.

NATURE COMMUNICATIONS (2019)

Review Endocrinology & Metabolism

Gut microbial metabolites in obesity, NAFLD and T2DM

Emanuel E. Canfora et al.

NATURE REVIEWS ENDOCRINOLOGY (2019)

Article Gastroenterology & Hepatology

Human gut microbiome: hopes, threats and promises

Patrice D. Cani

Article Neurosciences

Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation

Myungjin Jo et al.

JOURNAL OF NEUROSCIENCE (2017)

Letter Medicine, General & Internal

Arrhythmogenic Right Ventricular Cardiomyopathy

Sarju Ganatra et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Oncology

Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation

Neil M. Iyengar et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Cell Biology

Glucose Concentration and Streptomycin Alter In Vitro Muscle Function and Metabolism

Alastair Khodabukus et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2015)

Article Gastroenterology & Hepatology

Clostridium Butyricum MIYAIRI 588 Improves High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats

Makoto Seo et al.

DIGESTIVE DISEASES AND SCIENCES (2013)

Article Endocrinology & Metabolism

Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

Zhanguo Gao et al.

DIABETES (2009)

Article Multidisciplinary Sciences

An obesity-associated gut microbiome with increased capacity for energy harvest

Peter J. Turnbaugh et al.

NATURE (2006)

Article Microbiology

Extraction of Mycobacterium tuberculosis DNA:: a question of containment

W Somerville et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2005)